Saxagliptin hydrochloride
Selleck Chemicals
SKU:E6005-5MG
Couldn't load pickup availability

Saxagliptin hydrochloride is an inhibitor of DPP4 used in studies of Metabolic Signaling. In practice, this places the compound in experiments that measure metabolic regulation, energy sensing, and enzyme-linked homeostasis in endocrinology and metabolism models.
By inhibiting DPP4, Saxagliptin hydrochloride can be used to examine metabolic regulation, energy sensing, and enzyme-linked homeostasis. The protease annotation adds relevance to protease-activity, cleavage, and substrate-processing assays, together with downstream-response mapping in the same experimental setting. In endocrinology and metabolism models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Target-focused assays involving DPP4
- Pathway perturbation studies connected to Metabolic Signaling
- Concentration-response inhibition and target-dependence studies
- Protease-activity, cleavage, and substrate-processing assays
Overall, Saxagliptin hydrochloride is appropriate when a defined chemical perturbant is needed to connect DPP4 with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in endocrinology and metabolism models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Targets:
- DPP4
- Target Class:
- Protease
- Pathways:
- Metabolic Signaling
- Research Area:
- Endocrinology • Metabolism
- CAS No.:
- 709031-78-7
- Molecular Weight:
- 351.87
- Formula:
- C₁₈H₂₅N₃O₂·ClH
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.